Birchtech Files Brief in Federal Circuit Supporting the $78 Million Patent Infringement Judgment Against CERT Defendants

Birchtech filed an appellee brief on October 22, 2026, asking the Federal Circuit to uphold an approximately $78 million final judgment in its favor against the CERT defendants. The brief responds to the defendants’ appeal and addresses the jury’s findings on inducement, contributory infringement and damages; post-judgment interest continues to accrue while the appeal proceeds.

Analysis

The judgment is best treated as a contingent legal asset, not operating earnings: no cash benefit should be underwritten until the appeal is resolved and collectability is verified. The appellee brief may reinforce investor confidence, but the company’s account of the record is advocacy, not an independent read on appellate odds. Near term, BCHT may trade on headline sentiment; over the next several months, procedural developments matter more than the brief itself. An affirmance could improve expected recovery and strengthen the value of Birchte ch’s patent position, while reversal or remand could sharply reduce or delay the asset’s value. The longer-term deterrence benefit to patent enforcement is possible but should not be capitalized without evidence that it changes licensing or competitive behavior. Key missing inputs are the appeal schedule, any stay or bond, the applicable post-judgment interest rate, and defendants’ ability to pay. Ongoing interest accrual does not eliminate timing, reversal, or collection risk.

Key Decisions for Investors

• Do not treat the judgment or accruing interest as near-term revenue or cash flow. Before assigning value to recovery, verify the appeal schedule, stay/bond status, interest calculation, and defendants’ collectability.
• For days to weeks, avoid chasing a headline-driven BCHT move absent new court action; the brief itself does not resolve the merits. Reassess on material procedural orders or a ruling.
• For a 1–3 month event-driven watch, compare BCHT’s market-cap response with changes in the probability-weighted, collectible judgment value. If the share price discounts near-certain full recovery before appellate resolution, trim exposure rather than adding.
• Thesis falsifiers: an adverse appellate ruling, a remand that materially delays or narrows recovery, a stay or collection obstacle, or company disclosure indicating the judgment is not collectible. An affirmance plus credible collection evidence would strengthen the positive case.